Structural basis for the severe adverse interaction of sofosbuvir and amiodarone on L-type Cav channels - ScienceDirect
Treatment Options in Hepatitis C (09.01.2017)
Sofosbuvir (Sovaldi®)
Therapieerfolge nach Interferon-Therapie - 12 - 2014 - Heftarchiv - AMT
Advances in hepatitis B therapeutics - Vicente Soriano, Pablo Barreiro, Edward Cachay, Shyamasundaran Kottilil, José V. Fernandez-Montero, Carmen de Mendoza, 2020
Sofosbuvir - an overview | ScienceDirect Topics
Advances in Treatment of Hepatitis C | IntechOpen
Sofosbuvir/Velpatasvir/Voxilaprevir: A Highly Effective Option for Retreatment of Hepatitis C in Difficult-to-treat Patients - Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson, 2019
Sofosbuvir
Screen Shot 2017-01-01 at 8.20.43 PM.png
MYTH & REALITY OF SOFOSBUVIR IN PAKISTAN
Cardiovascular Risk Management and Hepatitis C: Combining Drugs | SpringerLink
Hepatitis C Virus
Solved What is the mechanism of action of Harvoni | Chegg.com
Sofosbuvir - Wikipedia
The ProTide Prodrug Technology: From the Concept to the Clinic | Journal of Medicinal Chemistry
Sofosbuvir/velpatasvir: A promising combination
Sofosbuvir, a Significant Paradigm Change in HCV Treatment
Sofosbuvir (Sovaldi) | Basicmedical Key
Sofosbuvir | Uses, Brand Names, Mechanism Of Action
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update | SpringerLink
What is the mechanism of action of sofosbuvir in the body? - Quora
Hepatitis C virus and the kidney | Nature Reviews Nephrology
Viruses | Free Full-Text | Hepatitis C Virus and Natural Compounds: A New Antiviral Approach?
